$10.41
2.16% yesterday
Nasdaq, Apr 11, 09:49 pm CET
ISIN
US6412881053
Symbol
NPCE

NeuroPace Inc Target price 2025 - Analyst rating & recommendation

NeuroPace Inc Classifications & Recommendation:

Buy
100%

NeuroPace Inc Price Target

Target Price $16.86
Price $10.42
Potential
Number of Estimates 7
7 Analysts have issued a price target NeuroPace Inc 2026 . The average NeuroPace Inc target price is $16.86. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 7 analysts: 7 Analysts recommend NeuroPace Inc to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the NeuroPace Inc stock has an average upside potential 2026 of . Most analysts recommend the NeuroPace Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 79.91 93.64
22.15% 17.18%
EBITDA Margin -24.90% -18.80%
36.29% 24.51%
Net Margin -35.09% -28.90%
40.05% 17.64%

7 Analysts have issued a sales forecast NeuroPace Inc 2025 . The average NeuroPace Inc sales estimate is

$93.6m
Unlock
. This is
17.18% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$96.0m 20.16%
Unlock
, the lowest is
$92.0m 15.13%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $79.9m 22.15%
2025
$93.6m 17.18%
Unlock
2026
$105m 11.83%
Unlock
2027
$132m 26.07%
Unlock
2028
$179m 35.66%
Unlock
2029
$215m 20.17%
Unlock

6 Analysts have issued an NeuroPace Inc EBITDA forecast 2025. The average NeuroPace Inc EBITDA estimate is

$-17.6m
Unlock
. This is
1.96% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-10.0m 42.10%
Unlock
, the lowest is
$-24.0m 38.97%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-19.9m 22.17%
2025
$-17.6m 11.52%
Unlock
2026
$-8.0m 54.53%
Unlock
2027
$2.4m 129.49%
Unlock
2028
$14.7m 523.27%
Unlock
2029
$30.8m 109.12%
Unlock

EBITDA Margin

2024 -24.90% 36.29%
2025
-18.80% 24.51%
Unlock
2026
-7.65% 59.31%
Unlock
2027
1.79% 123.40%
Unlock
2028
8.22% 359.22%
Unlock
2029
14.30% 73.97%
Unlock

4 NeuroPace Inc Analysts have issued a net profit forecast 2025. The average NeuroPace Inc net profit estimate is

$-27.1m
Unlock
. This is
4.52% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-24.1m 14.86%
Unlock
, the lowest is
$-28.9m 2.11%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-28.0m 26.77%
2025
$-27.1m 3.49%
Unlock
2026
$-18.5m 31.63%
Unlock
2027
$-10.3m 44.54%
Unlock

Net Margin

2024 -35.09% 40.05%
2025
-28.90% 17.64%
Unlock
2026
-17.67% 38.86%
Unlock
2027
-7.77% 56.03%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.93 -0.90
26.77% 3.23%
P/E negative
EV/Sales 3.84

4 Analysts have issued a NeuroPace Inc forecast for earnings per share. The average NeuroPace Inc EPS is

$-0.90
Unlock
. This is
4.26% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.80 14.89%
Unlock
, the lowest is
$-0.96 2.13%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.93 26.77%
2025
$-0.90 3.23%
Unlock
2026
$-0.61 32.22%
Unlock
2027
$-0.34 44.26%
Unlock

P/E ratio

Current -11.13 1.50%
2025
-11.61 4.31%
Unlock
2026
-16.98 46.25%
Unlock
2027
-30.62 80.33%
Unlock

Based on analysts' sales estimates for 2025, the NeuroPace Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.50 29.25%
2025
3.84 14.60%
Unlock
2026
3.44 10.58%
Unlock
2027
2.73 20.68%
Unlock
2028
2.01 26.28%
Unlock
2029
1.67 16.78%
Unlock

P/S ratio

Current 4.25 32.32%
2025
3.62 14.66%
Unlock
2026
3.24 10.58%
Unlock
2027
2.57 20.68%
Unlock
2028
1.89 26.28%
Unlock
2029
1.58 16.79%
Unlock

Current NeuroPace Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Cantor Fitzgerald
Locked
Locked
Locked Mar 05 2025
Wells Fargo
Locked
Locked
Locked Jan 30 2025
UBS
Locked
Locked
Locked Jan 21 2025
JP Morgan
Locked
Locked
Locked Dec 17 2024
Wells Fargo
Locked
Locked
Locked Nov 13 2024
Analyst Rating Date
Locked
Cantor Fitzgerald:
Locked
Locked
Mar 05 2025
Locked
Wells Fargo:
Locked
Locked
Jan 30 2025
Locked
UBS:
Locked
Locked
Jan 21 2025
Locked
JP Morgan:
Locked
Locked
Dec 17 2024
Locked
Wells Fargo:
Locked
Locked
Nov 13 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today